On July 1, 2024, DiaMedica Therapeutics Inc., closed the transaction. The company received funding pursuant to exemption provided under Regulation D, The transaction included participation from 10 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.89 USD | +3.21% |
|
-2.36% | +1.76% |
07-01 | DiaMedica Therapeutics Inc. announced that it has received $11.8 million in funding | CI |
06-27 | Transcript : DiaMedica Therapeutics Inc. - Special Call |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.76% | 110M | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.22% | 25.93B | |
-24.33% | 19.27B | |
-19.40% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Therapeutics Inc. announced that it has received $11.8 million in funding